Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytotec vs Angusta for Induction of Labor
NCT05424445Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in labor induction (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Vaginal delivery within 24 hours. Started Jan 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
labor induction
Beyond the preview
Go deeper on NCT05424445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05424445.